首页> 外文会议>World biomaterials congress >Nanosuspensions of poorly soluble drugs: Preparation and development by wet milling
【24h】

Nanosuspensions of poorly soluble drugs: Preparation and development by wet milling

机译:难溶性药物的纳米悬浮液:湿磨法制备和开发

获取原文

摘要

More than 40% of compounds identified by high-throughput screening are poorly water soluble. The low drug solubility leads to poor bioavailability. Nanosizing technique is an important approach to increase the drug solubility and dissolution rate, and further to imporve the drug biovalibility. Here, a fast wet milling was employed to prepare the nanosuspensions. 4 types of stabilizers (pluronic F68, pluronic F127, Tween 80 and PEG) at 4 different concentrations (10%, 25%, 60% and 80%, to drug amount) were performed on 2 structurally different drug substances: indomethacin and itraconazole. The effect of milling time, stabilizer type and concentration on particle size and size distribution were investigated. Photon correlation spectroscopy (PCS) results showed that nanosuspensions with the smallest size and polydisperisity index (PI) were obtained when 80 wt% F68 was used as the stabilizer for indomethacin and 60 wt% F127 for itraconazole. The morphology of nanoparticles was observed by transmission electron microscopy (TEM). The dissolution profiles of nanosuspensions and physical mixture suspensions were determined. Compared to the physical mixtures, dissolution rates of the nanosuspensions were significantly increased. The differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) were used to compare the crystalline state of the freeze-dried nanosuspensions before and after milling. The results indicated that the crystalline state of drugs were not changed by milling. The physical and chemical stability after 2 months storage at room temperature and at 4 °C were tested by PCS, TEM and high-performance liquid chromatography (HPLC). The nanosuspensions showed a good physical and chemical stability at both temperatures.
机译:通过高通量筛选鉴定出的化合物中,有40%以上的水溶性差。低的药物溶解度导致不良的生物利用度。纳米化技术是提高药物溶解度和溶解速度,进一步提高药物生物利用度的重要途径。在此,采用快速湿磨来制备纳米悬浮液。在2种结构不同的药物上使用了4种不同浓度(占药物量的10%,25%,60%和80%)的4种类型的稳定剂(普流尼克F68,普流尼克F127,吐温80和PEG):吲哚美辛和伊曲康唑。研究了研磨时间,稳定剂类型和浓度对粒度和粒度分布的影响。光子相关光谱法(PCS)结果表明,当吲哚美辛用作稳定剂为80 wt%F68,伊曲康唑为60 wt%F127时,可获得最小尺寸和多分散指数(PI)的纳米悬浮液。通过透射电子显微镜(TEM)观察纳米颗粒的形态。测定了纳米悬浮液和物理混合物悬浮液的溶出曲线。与物理混合物相比,纳米悬浮液的溶解速率显着提高。使用差示扫描量热法(DSC)和X射线粉末衍射(XRPD)来比较研磨前后纳米悬浮液的结晶状态。结果表明,药物的结晶状态没有通过研磨而改变。通过PCS,TEM和高效液相色谱(HPLC)测试了在室温和4°C下保存2个月后的物理和化学稳定性。纳米悬浮液在两个温度下均显示出良好的物理和化学稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号